 |
PDBsum entry 4qfg
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein/inhibitor
|
PDB id
|
|
|
|
4qfg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
366 a.a.
|
 |
|
|
|
|
|
|
|
161 a.a.
|
 |
|
|
|
|
|
|
|
287 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein/inhibitor
|
 |
|
Title:
|
 |
Structure of ampk in complex with staurosporine inhibitor and in the absence of a synthetic activator
|
|
Structure:
|
 |
5'-amp-activated protein kinase catalytic subunit alpha-1. Chain: a. Fragment: ampk alpha1. Synonym: ampk subunit alpha-1, acetyl-coa carboxylase kinase, acaca kinase, hydroxymethylglutaryl-coa reductase kinase, hmgcr kinase, tau-protein kinase prkaa1. Ec: 2.7.11.1, 2.7.11.27, 2.7.11.31, 2.7.11.26. Engineered: yes. Mutation: yes.
|
|
Source:
|
 |
Rattus norvegicus. Brown rat,rat,rats. Organism_taxid: 10116. Gene: ampk1, prkaa1, prkaa1 ampk1. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: prkab1. Gene: prkag1. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
3.46Å
|
R-factor:
|
0.224
|
R-free:
|
0.267
|
|
|
Authors:
|
 |
M.F.Calabrese,R.G.Kurumbail
|
|
Key ref:
|
 |
M.F.Calabrese
et al.
(2014).
Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms.
Structure,
22,
1161-1172.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-May-14
|
Release date:
|
06-Aug-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P54645
(AAPK1_RAT) -
5'-AMP-activated protein kinase catalytic subunit alpha-1 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
559 a.a.
366 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chain A:
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
Bound ligand (Het Group name = )
matches with 85.19% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
Bound ligand (Het Group name = )
matches with 85.19% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.2.7.11.26
- [tau protein] kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[tau protein] + ATP = O-phospho-L-seryl-[tau protein] + ADP + H+
|
|
2.
|
L-threonyl-[tau protein] + ATP = O-phospho-L-threonyl-[tau protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[tau protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[tau protein]
Bound ligand (Het Group name = )
matches with 85.19% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[tau protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[tau protein]
Bound ligand (Het Group name = )
matches with 85.19% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain A:
E.C.2.7.11.31
- [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-seryl-[3-hydroxy-3-methylglutaryl-coenzyme A reductase] + ATP = O-phospho-L-seryl-[3-hydroxy-3-methylglutaryl-coenzyme A reductase] + ADP + H+
|
 |
 |
 |
 |
 |
L-seryl-[3-hydroxy-3-methylglutaryl-coenzyme A reductase]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[3-hydroxy-3-methylglutaryl-coenzyme A reductase]
Bound ligand (Het Group name = )
matches with 85.19% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Structure
22:1161-1172
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms.
|
|
M.F.Calabrese,
F.Rajamohan,
M.S.Harris,
N.L.Caspers,
R.Magyar,
J.M.Withka,
H.Wang,
K.A.Borzilleri,
P.V.Sahasrabudhe,
L.R.Hoth,
K.F.Geoghegan,
S.Han,
J.Brown,
T.A.Subashi,
A.R.Reyes,
R.K.Frisbie,
J.Ward,
R.A.Miller,
J.A.Landro,
A.T.Londregan,
P.A.Carpino,
S.Cabral,
A.C.Smith,
E.L.Conn,
K.O.Cameron,
X.Qiu,
R.G.Kurumbail.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
AMP-activated protein kinase (AMPK) is a principal metabolic regulator affecting
growth and response to cellular stress. Comprised of catalytic and regulatory
subunits, each present in multiple forms, AMPK is best described as a family of
related enzymes. In recent years, AMPK has emerged as a desirable target for
modulation of numerous diseases, yet clinical therapies remain elusive.
Challenges result, in part, from an incomplete understanding of the structure
and function of full-length heterotrimeric complexes. In this work, we provide
the full-length structure of the widely expressed α1β1γ1 isoform of mammalian
AMPK, along with detailed kinetic and biophysical characterization. We
characterize binding of the broadly studied synthetic activator A769662 and its
analogs. Our studies follow on the heels of the recent disclosure of the
α2β1γ1 structure and provide insight into the distinct molecular mechanisms
of AMPK regulation by AMP and A769662.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |